First-line carboplatin, pemetrexed, and panitumumab in patients with advanced nonsquamous KRAS wild type (WT) non-small cell lung cancer (NSCLC)
Meeting Abstract
Mekhail, Tarek, Waterhouse, David Michael, Hadley, Terence J., Webb, Charles D., Burris, Howard A., Hainsworth, John D., Greco, F. Anthony, Spigel, David R.